Vir Biotechnology (VIR) Intangibles (2018 - 2026)
Vir Biotechnology (VIR) recorded Intangibles of $7.7 million in Q2 2026, down 3.7% from $8 million a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Intangibles (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology reported Intangibles of $7.85 million, down 3.3% from FY2024.
- Annual Intangibles has declined for seven straight years, with a five-year compound annual growth rate of -25.3% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $8.12 million in FY2024 (-64.0%), $22.57 million in FY2023 (-31.1%), $32.76 million in FY2022 (-1.6%) and $33.29 million in FY2021 (-1.6%).
- The Q2 2026 figure is the lowest quarterly Intangibles in data going back to Q4 2018.
- On a year-over-year basis, Intangibles has declined for 24 consecutive quarters, with an average decline of 35.0% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 1.5% (Q3 2021) and 64.1% (Q1 2025) over the last five years.
- Per Business Quant, the preceding three quarters came in at $7.78 million (Q1 2026), $7.85 million (Q4 2025) and $7.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | 7.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.70 Mn |
| Mar 31, 2026 | 7.78 Mn |
| Dec 31, 2025 | 7.85 Mn |
| Sep 30, 2025 | 7.92 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 8.12 Mn |
| Sep 30, 2024 | 19.26 Mn |
| Jun 30, 2024 | 18.90 Mn |
| Mar 31, 2024 | 22.47 Mn |
| Dec 31, 2023 | 22.57 Mn |
| Sep 30, 2023 | 25.46 Mn |
| Jun 30, 2023 | 25.59 Mn |
| Mar 31, 2023 | 32.62 Mn |
| Dec 31, 2022 | 32.76 Mn |
| Sep 30, 2022 | 32.89 Mn |
| Jun 30, 2022 | 33.02 Mn |
| Mar 31, 2022 | 33.15 Mn |
| Dec 31, 2021 | 33.29 Mn |
| Sep 30, 2021 | 33.42 Mn |
API Access
Vir Biotechnology Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();